RESEARCH TRIANGLE PARK – Gene editing startup Locus Biosciences is another step closer to actualizing its biotherapeutics against bacterial diseases after landing $35 million in additional capital.
SAN FRANCISCO, Aug. 27, 2020 /PRNewswire/ -- Locus, a global B2B SaaS company that automates human decisions in logistics, today announced its recognition in Gartner's "Hype Cycle for Transportation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results